Status:
COMPLETED
Intraosseous vs Submucosal Injection of Dexamethasone
Lead Sponsor:
Hams Hamed Abdelrahman
Conditions:
Tooth, Impacted
Eligibility:
All Genders
18-40 years
Phase:
NA
Brief Summary
Thirty-eight patients were randomly divided into 2 groups; the intraosseous injection group of dexamethasone (4 mg) and the submucosal injection group. All surgeries were performed by one surgeon. Po...
Eligibility Criteria
Inclusion
- Inclusion criteria
- Patient complaining of impacted mandibular third molar mesioangular or horizontal, according to the Pell and Gregory classification 1933)
- Healthy patient (American society of anesthesiologists class I status)
- Patient age range from 18 to 40 years old.
- Patient without any local inflammation or pathology.
- Patient who will able to understand verbal and written instructions.
- Exclusion criteria
- Pregnant or breast-feeding women.
- Patient had anti-inflammatory drugs within 2 weeks before the procedure.
- Patient under radiotherapy or chemotherapy.
- Habits (heavy smoking and alcoholic).
- Allergy to drugs used in this study.
- Patient under anticoagulant or corticosteroid therapy.
Exclusion
Key Trial Info
Start Date :
August 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 30 2020
Estimated Enrollment :
38 Patients enrolled
Trial Details
Trial ID
NCT04718077
Start Date
August 1 2020
End Date
December 30 2020
Last Update
January 22 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Outpatient Clinic of Oral and Maxillofacial Surgery Department, Faculty of Dentistry, Alexandria University, Egypt
Alexandria, Azarita, Egypt, 00203